.png){kind=logo}
Artificial intelligence is changing the diagnosis of rare diseases, enabling faster detections and personalized treatments, find out how.
Diagnosing rare diseases has historically been a challenge for healthcare professionals. With more than 7,000 rare diseases identified worldwide, millions of patients face lengthy diagnostic processes and limited therapeutic options. Today, artificial intelligence (AI) is revolutionizing this landscape, offering new tools to improve accuracy and speed in identifying these conditions.
The International Rare Diseases Research Consortium (IRDiRC) has established an innovative framework that seeks to integrate AI into the diagnosis and treatment of these pathologies. Its goal is ambitious: to develop 1,000 new therapies and methodologies by 2027. This approach not only optimizes access to diagnosis, but also makes it possible to personalize treatments more efficiently, benefiting both patients and healthcare professionals.
The application of AI in the identification and treatment of rare diseases has shown promising results. For example:
Platforms such as HealX are using AI to discover reusable drugs in the treatment of rare diseases, significantly reducing the time needed to find effective therapies.
Phenotype-based diagnostics, supported by entities such as the NIH and FDA, allow physicians to identify these pathologies with greater accuracy.
Genetic analysis with AI, facilitating the personalization of treatments and improving clinical outcomes for each patient.
While AI opens a new horizon in diagnosing rare diseases, it also faces crucial challenges:
Data privacy and security: Protection of genetic and clinical information is a key challenge in the adoption of these technologies.
Equity in access: It is essential to ensure that these innovations reach all healthcare units, regardless of their geographic location or resources.
Interdisciplinary collaboration: The combination of technology, research and clinical practice is essential to maximize the impact of AI in this field.
As AI continues to evolve, its integration into the diagnosis of rare diseases represents an unprecedented opportunity for medicine. Healthcare professionals and the pharmaceutical industry must work together to harness its full potential and overcome the challenges it presents.
At Arkangel AI, we are committed to driving the research and application of AI in healthcare, ensuring that these innovations reach those who need them most. Learn more about our advances here.
If you want to have real-time information on technological advances in healthcare and learn more about our AI tools, join our community: https://www.arkangel.ai/ai-heroes
Do you have a project in mind or would you like to discover how to implement AI in healthcare? Make an appointment with our President, click here.
